Transglutaminase type 2 plays a key role in the pathogenesis of <i>Mycobacterium tuberculosis</i> infectionIvana Palucci, Giovanni Delogu, Federica Rossin et al.|Journal of Internal Medicine|2017Cited by 28
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 AxisLuca Occhigrossi, Mauro Piacentini, Federica Rossin et al.|The Journal of Immunology|2021Cited by 25
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 TherapyTonino Alonzi, Delia Goletti, Alessandra Aiello et al.|Cells|2021Cited by 17
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with AmikacinIvana Palucci, Giovanni Delogu, Alessandro Salustri et al.|International Journal of Molecular Sciences|2023Cited by 12